J. L. Sullivan
About
In The Last Decade
J. L. Sullivan
18 papers receiving 487 citations
Peers
Comparison fields: 5 of 88
- Epidemiology 153
- Molecular Biology 87
- Immunology 76
- Pediatrics, Perinatology and Child Health 74
- Pulmonary and Respiratory Medicine 67
Countries citing papers authored by J. L. Sullivan
This map shows the geographic impact of J. L. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Sullivan more than expected).
Fields of papers citing papers by J. L. Sullivan
This network shows the impact of papers produced by J. L. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Sullivan. The network helps show where J. L. Sullivan may publish in the future.
Co-authorship network of co-authors of J. L. Sullivan
This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Sullivan. A scholar is included among the top collaborators of J. L. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Sullivan. J. L. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 2 | |
| 3 | 22 | |
| 4 | 7 | |
| 5 | The latent membrane protein 1 deletion variant with enhanced oncogenic activity prevails in acute infectious mononucleosis and EBV-associated tonsillar hyperplasia | 1 |
| 6 | 43 | |
| 7 | 13 | |
| 8 | 14 | |
| 9 | 59 | |
| 10 | 22 | |
| 11 | 80 | |
| 12 | Iron depletion decreases lung injury after systemic complement activation | 9 |
| 13 | Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. | 48 |
| 14 | 15 | |
| 15 | Primary malignant carcinoid of the testis. | 23 |
| 16 | 37 | |
| 17 | 13 | |
| 18 | 76 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.